FIELD: chemistry.
SUBSTANCE: described are novel pyrazine triazinone derivatives of general formula 
wherein Ra represents C1-C6 alkyl, C2-C6 alkenyl or C2-C6 alkinyl; Rb represents phenyl, substituted with acyl, alkoxy, hydroxyl, nitro, NH2, thioalkyl group or -C(=O)Re, where Re is C1-C6 alkyl, or group -C(=O)Re, where Re represents C1-C6 alkyl or cyclopropyl and Rp represents -H, -PO3H2, -HPO3 -Na+, -PO3 2-Na2 +, pharmaceutical composition, containing thereof, and method of treating acute myeloleukosis.
EFFECT: novel compounds represent reverse turn mimetics and can be applied in medicine.
9 cl, 1 dwg, 3 tbl, 24 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEW COMPOUNDS MIMETICS AND USING THEM | 2008 |
|
RU2457210C2 |
| NEW OXAZOLIDINONE DERIVATIVE AND PHARMACEUTICAL COMPOSITION THAT INCLUDES IT | 2012 |
|
RU2617408C2 |
| PYRIMIDINE DERIVATIVES | 2002 |
|
RU2320658C2 |
| ESTER DERIVATIVES AND THEIR MEDICAL APPLICATION | 2005 |
|
RU2431480C2 |
| NEW BIPHENYL COMPOUND OR ITS SALT | 2016 |
|
RU2726622C2 |
| DERIVATIVES OF PYRROLOPYRIMIDINE, METHOD FOR PREPARING AND THEIR USING | 2001 |
|
RU2263676C2 |
| 1,2,4-TRIAZOLE DERIVATIVES AS SIGMA RECEPTOR INHBITORS | 2007 |
|
RU2451015C2 |
| METHOD FOR PREDICTING THE THERAPEUTIC EFFECT OF AN LSD 1INHIBITOR BASED ON THE INSM1 EXPRESSION | 2018 |
|
RU2789449C2 |
| TETRAHYDROINDENOINDOLE COMPOUNDS, METHODS OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION SHOWING ANTIOXIDANT ACTIVITY, ANTIOXIDANT COMPOSITION AND A METHOD OF STABILIZATION OF COMPOUNDS EXHIBITING SENSITIVITY TO OXIDATION | 1990 |
|
RU2104270C1 |
| NEW BIPHENYL COMPOUND OR ITS SALT | 2018 |
|
RU2765152C2 |
